CCM
IBB icon

Context Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Context Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,000
Closed -$515K – 34
2016
Q2 		$515K Buy
+6,000
New +$538K 0.6% 29

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Context Capital Management's IBB Position: Q3 2016 in Review

Context Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 6,000 shares — an estimated $515K sold.

Context Capital Management first reported a position in IBB in Q2 2016 and held it in 1 quarter. The position peaked at $515K in Q2 2016. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

  • Context Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
  • Context Capital Management sold 6,000 iShares Biotechnology ETF shares in Q3 2016, an estimated $515K.
  • Context Capital Management first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 1 quarter.
  • Context Capital Management's iShares Biotechnology ETF position peaked at $515K in Q2 2016.
  • 463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Context Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.